| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |